secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kymera Therapeutics, Inc. (KYMR)
CIK:        0001815442
Form:       8-K
Filed at:   2022-04-11T23:59:59+00:00
Accession:  0001193125-22-101673
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Kymera Therapeutics director Steven Hall not standing for reelection at 2022 annual meeting
--------------------------------------------------------------------------------

- Director Steven Hall informed board he will not stand for reelection at 2022 annual meeting.
- Hall's departure is not due to any disagreement with the company.
- Hall served on the Compensation Committee; company thanks him for service.
- No replacement announced; Hall will serve until end of his current term.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815442/000119312522101673/0001193125-22-101673-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815442/000119312522101673/d291982d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-101673

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer